Randomized Trial Using Standard Dose Versus High Dose Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Diffuse Large B Cell Lymphomas.
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Rituximab (Primary) ; Carmustine; Cytarabine; Etoposide; Melphalan
- Indications Diffuse large B cell lymphoma; Follicular lymphoma
- Focus Therapeutic Use
- 07 Jun 2016 Primary endpoint (Disease-free survival rate) has not been met, as per the results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 22 Jun 2012 Actual end date (1 Jun 2012) added as reported by ClinicalTrials.gov.